David M. Stout
Board of Director
Pharmaceutical Executive
NanoBio Corporation
United States of America
Biography
David M. Stout has served as a top-level pharmaceutical executive, both nationally and internationally, for the past 30 years. His most recent position was President of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals. In this capacity, he led all global commercial activities, global manufacturing, and all vaccine-related activities for the company, including research and development. Additionally, Mr. Stout directed the corporate pandemic flu preparedness program – an international effort that supports governments, health authorities, and company employees around the world in responding to a global influenza pandemic. Prior to his tenure at GSK, Mr. Stout served as President of SmithKline Beecham’s North American pharmaceutical business, launching two major products and two sales force expansions. His pharmaceutical career began at Warner-Lambert Pharmaceutical Company and continued at Schering-Plough Corporation, where he served in numerous positions, including President of Schering Laboratories.
Research Interest
Pharmaceuticals
